Rodríguez P.C.
90
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 9 |
| Inmunología | 3 |
| Medicina interna | 2 |
| Medicamento | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 7 |
| Farmacología y terapéutica | 4 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Carmen Elena Viada | 6 |
| Tania Crombet | 5 |
| Neninger Vinageras E. | 5 |
| García Verdecia B. | 4 |
| Lage Davila A. | 4 |
| Luaces P.L.o. | 3 |
| Popa X. | 3 |
| Mazorra Z. | 2 |
| Montero E. | 2 |
| De La Torre A.V. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
ReviewAbstract: Epidermal growth factor receptor (EGFR) is overexpressed in many epithelial tumors and its role in tPalabras claves:cancer vaccine, clinical trials, Epidermal growth factor, Epidermal growth factor receptor, lung cancer, Non-small-cell lung cancerAutores:García Verdecia B., Lage Davila A., Neninger Vinageras E., Rodríguez P.C., Tania CrombetFuentes:scopusEvaluation of quality of life in patients with non-small cell lung cancer treated with CIMAvaxEGF® vaccine
ArticleAbstract: This report corresponds to quality of life analysis of patient with non-small cell lung cancer incluPalabras claves:Cancer Vaccines, clinical trials, Non-small cell lung cancer, quality of life, surveys and questionnairesAutores:Álvarez-Cardona M., Carmen Elena Viada, Crombet-Ramos T., Frías-Blanco A., Lorenzo-Monteagudo G., Neninger-Vinagera E., Ramos-Suzarte M., Rodríguez P.C.Fuentes:scopusDifferential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer
ArticleAbstract: Background: Progress in immunotherapy has revolutionized the treatment landscape for advanced lung cPalabras claves:immunotherapy, long-term survival, non–small cell lung cancer, survival mixture modelsAutores:Alfonso S., Carmen Elena Viada, Lage Davila A., Luaces P.L.o., Muchene L., Neninger Vinageras E., Rodríguez P.C., Sánchez L., Shkedy Z., Tania CrombetFuentes:scopusSafety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
ArticleAbstract: The prognosis of patients with advanced non small cell lung (NSCLC) cancer remains dismal. EpidermalPalabras claves:Autores:Carmen Elena Viada, García Verdecia B., González G., Lage Davila A., Luaces P.L.o., Montero E., Neninger Vinageras E., Popa X., Rodríguez P.C., Tania CrombetFuentes:scopusAnti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule
ArticleAbstract: We previously reported that CIMAvax-EGF vaccine is safe, immunogenic and efficacious to treat advancPalabras claves:antibodies affinity, cancer vaccine, EGF, NSCLC, surrogate biomarkerAutores:Alvarez K., Carmen Elena Viada, Fuentes K.P., García Verdecia B., González A., Gonzalez Z., Huerta V., Mazorra Z., Neninger Vinageras E., Popa X., Rodríguez P.C., Tania CrombetFuentes:scopus